Clinical trial
Hepatocellular Carcinoma Recurrence and Anesthesia
NCT02643173 is registered in ClinicalTrials.gov with Seoul National University Bundang Hospital as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Hepatocellular Carcinoma Recurrence and Anesthesia
- Lead sponsor
- Seoul National University Bundang Hospital
- Phase
- Observational
- Overall status
- Completed
- Start date
- September 30, 2015
- Completion date
- June 30, 2019
- Enrollment
- 259 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
hepatocellular carcinoma